Skip to Main Navigation

Emergency Tuberculosis Project

Abstract*

The objective of the Emergency Tubercolosis Project is to improve the quality and expand the coverage and utilization of health services to control the spread of tuberculosis in targeted areas of Papua New Guinea by strengthening programmatic management of tuberculosis. There are three components to the project, the first component being early detection of active tuberculosis patients. The IDA credit will finance the implementation of ACF strategies...

* The project abstract is drawn from the PAD, SAR or PGD and may not accurately reflect the project's current nature

Show More

Development Objective

To Improve the quality and expand the coverage and utilization of health services to control the spread of tuberculosis in targeted areas of Papua New Guinea by strengthening programmatic management of tuberculosis.

Key Details

Project Details

  • P160947

  • Closed

  • Edith Digwaleu-Kariko

  • Independent State of Papua New Guinea

  • Papua New Guinea

  • October 26, 2016

  • (as of board presentation)

    May 31, 2017

  • September 25, 2017

  • US$ 15.00 million

  • National Department of Health

  • East Asia and Pacific

  • 2017

  • US$ 15.00 million

  • B

  • March 15, 2024

  • June 15, 2024

  • Yes

  • BANK APPROVED

  • Notes

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
IDA Credit 15.00

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment N/A
IDA Commitment 15.00
IBRD + IDA Commitment 15.00
Lending Instrument
Grant Amount N/A
Total Project Cost** 15.00

Summary Status of World Bank Financing (US$ Millions) as of March 31, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of March 31, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)
Jun 21, 2024 IDA-60670 Loan Disb 98,404.74
Jun 1, 2024 IDA-60670 Int Charges 4,387.22
Jun 1, 2024 IDA-60670 Loan Repay 242,406.34
Feb 5, 2024 IDA-60670 Loan Disb 525,439.00
Feb 6, 2024 IDA-60670 Loan Disb 89,814.41
May 31, 2017 IDA-60670 Loan Commitment 15,000,000.00
May 13, 2024 IDA-60670 Loan Disb 44,675.06
Jun 1, 2024 IDA-60670 Int Charges 35,682.43
Jun 1, 2024 IDA-60670 Int Charges 35,682.43
Jun 1, 2024 IDA-60670 Int Charges 57,762.75
May 13, 2024 IDA-60670 Loan Disb 79,017.14
May 13, 2024 IDA-60670 Loan Disb 50,623.78
May 13, 2024 IDA-60670 Loan Disb 28,024.51
Mar 13, 2024 IDA-60670 Loan Disb 41,549.74
Mar 13, 2024 IDA-60670 Loan Disb 37,209.16
Feb 15, 2024 IDA-60670 Loan Disb 48,397.94
Feb 23, 2024 IDA-60670 Loan Disb 40,104.36
Feb 13, 2024 IDA-60670 Loan Disb 73,170.82
Jan 30, 2024 IDA-60670 Loan Disb 22,145.77
Apr 23, 2021 IDA-60670 Loan Disb 8,628.04
Apr 19, 2021 IDA-60670 Loan Disb 11,482.08
May 24, 2021 IDA-60670 Loan Disb 11,452.89
Jun 2, 2021 IDA-60670 Loan Disb 14,819.62
Apr 30, 2021 IDA-60670 Loan Disb 8,140.17
Dec 10, 2020 IDA-60670 Loan Disb 5,811.00
Dec 7, 2020 IDA-60670 Loan Disb 261,926.27
Dec 7, 2020 IDA-60670 Int Charges 381.82
Dec 7, 2020 IDA-60670 Int Charges 16,373.50
Dec 7, 2020 IDA-60670 Int Charges 16,373.50
Dec 7, 2020 IDA-60670 Int Charges 26,480.83
Dec 14, 2020 IDA-60670 Loan Disb 13,313.29
Dec 10, 2020 IDA-60670 Loan Disb 11,482.07
Sep 9, 2020 IDA-60670 Loan Disb 11,482.08
Nov 17, 2020 IDA-60670 Loan Disb 9,684.62
Jul 29, 2020 IDA-60670 Loan Disb 10,234.71
Aug 25, 2020 IDA-60670 Loan Disb 5,695.15
Oct 5, 2020 IDA-60670 Loan Disb 11,452.88
Oct 19, 2020 IDA-60670 Loan Disb 9,066.87
Jun 2, 2020 IDA-60670 Loan Disb 8,320.00
Jun 30, 2020 IDA-60670 Loan Disb 12,893.65
Jun 23, 2020 IDA-60670 Loan Disb 13,056.91
Sep 25, 2020 IDA-60670 Loan Disb 20,860.45
Sep 1, 2020 IDA-60670 Loan Disb 6,805.50
Jul 27, 2020 IDA-60670 Loan Disb 13,589.53
Aug 19, 2020 IDA-60670 Loan Disb 12,011.67
May 7, 2020 IDA-60670 Loan Disb 32,110.11
Jun 4, 2020 IDA-60670 Loan Disb 12,011.66
Jun 1, 2020 IDA-60670 Int Charges 1,051.41
Jun 1, 2020 IDA-60670 Int Charges 14,815.78
Jun 1, 2020 IDA-60670 Int Charges 14,815.78
Jun 1, 2020 IDA-60670 Int Charges 24,328.10
May 26, 2020 IDA-60670 Loan Disb 7,714.03
Apr 2, 2020 IDA-60670 Loan Disb 24,109.24
Apr 15, 2020 IDA-60670 Loan Disb 13,128.89
Apr 9, 2020 IDA-60670 Loan Disb 11,794.53
Feb 25, 2020 IDA-60670 Loan Disb 11,794.52
Jan 23, 2020 IDA-60670 Loan Disb 15,582.04
May 8, 2020 IDA-60670 Loan Disb 11,794.53
Dec 3, 2019 IDA-60670 Loan Disb 21,221.00
Sep 14, 2022 IDA-60670 Loan Disb 8,319.49
Sep 14, 2022 IDA-60670 Loan Disb 10,681.17
Dec 21, 2021 IDA-60670 Loan Disb 23,599.88
Oct 4, 2022 IDA-60670 Loan Disb 10,167.28
Jan 28, 2022 IDA-60670 Loan Disb 7,161.63
Jul 29, 2022 IDA-60670 Loan Disb 11,982.35
Dec 30, 2022 IDA-60670 Loan Disb 9,562.46
May 25, 2022 IDA-60670 Loan Disb 10,056.75
Jun 1, 2022 IDA-60670 Loan Repay 530.90
Jun 1, 2022 IDA-60670 Loan Repay 246,564.10
May 11, 2022 IDA-60670 Loan Disb 7,416.73
Jun 1, 2022 IDA-60670 Int Charges 35,721.33
Jun 1, 2022 IDA-60670 Int Charges 21,432.78
Jun 1, 2022 IDA-60670 Int Charges 21,432.78
Dec 21, 2021 IDA-60670 Int Charges 18,941.49
Dec 21, 2021 IDA-60670 Int Charges 18,941.49
Dec 21, 2021 IDA-60670 Int Charges 31,569.17
Dec 21, 2021 IDA-60670 Int Charges 498.96
Apr 8, 2022 IDA-60670 Loan Disb 265,166.47
Dec 7, 2021 IDA-60670 Loan Disb 199,152.90
Dec 7, 2021 IDA-60670 Loan Disb 21,057.15
Dec 7, 2021 IDA-60670 Loan Disb 221,399.62
Dec 7, 2021 IDA-60670 Loan Disb 264,422.62
Dec 15, 2021 IDA-60670 Loan Disb 41,226.22
May 27, 2022 IDA-60670 Loan Disb 63,192.65
Mar 22, 2022 IDA-60670 Loan Disb 4,054.97
Feb 22, 2022 IDA-60670 Loan Disb 9,637.04
Mar 11, 2022 IDA-60670 Loan Disb 8,333.15
May 31, 2022 IDA-60670 Loan Disb 41,659.08
Sep 2, 2021 IDA-60670 Loan Disb 11,423.45
Nov 12, 2021 IDA-60670 Loan Disb 10,723.45
Mar 25, 2021 IDA-60670 Loan Disb 355,592.50
Jun 9, 2021 IDA-60670 Loan Disb 11,482.07
Jun 17, 2021 IDA-60670 Int Charges 29,714.33
Apr 28, 2021 IDA-60670 Loan Disb 6,298.50
Jun 17, 2021 IDA-60670 Int Charges 805.22
Jun 17, 2021 IDA-60670 Int Charges 18,134.93
Jun 17, 2021 IDA-60670 Int Charges 18,134.93
Jul 28, 2021 IDA-60670 Loan Disb 24,449.85
Jul 23, 2021 IDA-60670 Loan Disb 11,452.88
Jan 30, 2024 IDA-60670 Loan Disb 33,580.04
Jan 30, 2024 IDA-60670 Loan Disb 64,474.04
Jan 30, 2024 IDA-60670 Loan Disb 11,572.74
Feb 2, 2024 IDA-60670 Loan Disb 10,381.28
Feb 2, 2024 IDA-60670 Loan Disb 1,311,858.00
Feb 1, 2024 IDA-60670 Loan Disb 160,718.27
Mar 7, 2024 IDA-60670 Loan Disb 364,294.70
Apr 24, 2024 IDA-60670 Loan Disb 10,283.63
Apr 24, 2024 IDA-60670 Loan Disb 43,374.01
Feb 22, 2024 IDA-60670 Loan Disb 385,723.80
Mar 21, 2024 IDA-60670 Loan Disb 50,611.65
Apr 16, 2024 IDA-60670 Loan Disb 18,276.27
Apr 16, 2024 IDA-60670 Loan Disb 44,632.70
Apr 16, 2024 IDA-60670 Loan Disb 31,477.60
Apr 16, 2024 IDA-60670 Loan Disb 35,654.85
Apr 16, 2024 IDA-60670 Loan Disb 26,284.61
Jun 18, 2024 IDA-60670 Loan Disb 33,265.85
May 17, 2024 IDA-60670 Loan Disb 124,680.18
Apr 3, 2024 IDA-60670 Loan Disb 59,326.35
Aug 9, 2024 IDA-60670 Loan Disb 35,055.91
Jul 19, 2024 IDA-60670 Loan Disb 793,620.56
Aug 22, 2024 IDA-60670 Loan Disb 106,263.19
Apr 3, 2024 IDA-60670 Loan Disb 19,852.35
Jul 9, 2024 IDA-60670 Loan Disb 35,055.91
Mar 19, 2024 IDA-60670 Loan Disb 10,825.27
Jan 30, 2024 IDA-60670 Loan Disb 43,123.87
Jan 23, 2024 IDA-60670 Loan Disb 69,792.17
Jan 23, 2024 IDA-60670 Loan Disb 566,716.00
Jan 23, 2024 IDA-60670 Loan Disb 77,692.52
Nov 14, 2023 IDA-60670 Loan Disb 17,816.19
Oct 23, 2023 IDA-60670 Loan Disb 14,670.67
Jun 14, 2024 IDA-60670 Loan Disb 26,948.39
Jun 14, 2024 IDA-60670 Loan Disb 100,316.47
Aug 20, 2024 IDA-60670 Loan Disb 111,561.43
Apr 3, 2024 IDA-60670 Loan Disb 20,985.87
Jun 14, 2024 IDA-60670 Loan Disb 59,010.17
Jun 14, 2024 IDA-60670 Loan Disb 129,144.26
Jun 14, 2024 IDA-60670 Loan Disb 18,397.32
Apr 12, 2024 IDA-60670 Loan Disb 49,303.17
Jun 14, 2024 IDA-60670 Loan Disb 45,349.96
Apr 12, 2024 IDA-60670 Loan Disb 175,968.00
Jul 9, 2024 IDA-60670 Loan Disb -34,995.07
Nov 3, 2023 IDA-60670 Loan Disb 37,640.37
Nov 22, 2023 IDA-60670 Loan Disb 8,222.52
Dec 1, 2023 IDA-60670 Int Charges 24,987.83
Dec 1, 2023 IDA-60670 Int Charges 37,230.29
Dec 1, 2023 IDA-60670 Loan Repay 240,372.98
Dec 1, 2023 IDA-60670 Int Charges 24,987.83
Dec 1, 2023 IDA-60670 Loan Repay 3,630.44
Nov 20, 2023 IDA-60670 Loan Disb 43,368.30
Dec 20, 2023 IDA-60670 Loan Disb 28,406.26
Jan 8, 2024 IDA-60670 Loan Disb 31,788.40
Oct 4, 2023 IDA-60670 Loan Disb 25,206.90
Oct 16, 2023 IDA-60670 Loan Disb 53,074.06
Oct 26, 2023 IDA-60670 Loan Disb 18,965.43
Jun 1, 2023 IDA-60670 Int Charges 11,983.29
Jun 1, 2023 IDA-60670 Loan Repay 243,585.84
Jun 1, 2023 IDA-60670 Int Charges 39.55
Jun 1, 2023 IDA-60670 Int Charges 39.55
Jul 17, 2023 IDA-60670 Loan Disb 533,286.00
Jun 1, 2023 IDA-60670 Int Charges 22,853.09
Jun 1, 2023 IDA-60670 Int Charges 22,853.09
Jun 1, 2023 IDA-60670 Int Charges 38,088.51
Jun 1, 2023 IDA-60670 Int Charges 65.91
Dec 1, 2023 IDA-60670 Loan Disb 53,700.00
Jun 1, 2023 IDA-60670 Loan Disb 315,700.00
Jun 20, 2023 IDA-60670 Loan Disb 14,584.46
Sep 1, 2023 IDA-60670 Loan Disb 14,584.45
Jul 19, 2023 IDA-60670 Loan Disb 14,584.46
Sep 15, 2023 IDA-60670 Loan Disb 14,718.44
Mar 28, 2023 IDA-60670 Loan Disb 14,438.43
Sep 26, 2022 IDA-60670 Loan Disb 246,396.95
Dec 1, 2022 IDA-60670 Loan Repay 6,230.42
Dec 9, 2022 IDA-60670 Loan Repay 237,132.19
Dec 9, 2022 IDA-60670 Int Charges 22,210.44
Dec 9, 2022 IDA-60670 Int Charges 22,210.44
Dec 9, 2022 IDA-60670 Int Charges 25,043.18
Mar 8, 2023 IDA-60670 Loan Disb 14,623.40
Oct 6, 2022 IDA-60670 Loan Disb 263,926.22
Dec 12, 2022 IDA-60670 Loan Disb 15,436.32
Jun 18, 2019 IDA-60670 Loan Disb 1,799,787.00
Jun 17, 2019 IDA-60670 Loan Disb 13,697.38
Apr 26, 2019 IDA-60670 Loan Disb 6,706.69
May 21, 2018 IDA-60670 Loan Disb 62,300.00
Feb 6, 2019 IDA-60670 Loan Disb 14,213.91
Dec 13, 2018 IDA-60670 Loan Disb 311,450.00
Feb 6, 2019 IDA-60670 Loan Disb 13,697.38
Dec 4, 2018 IDA-60670 Int Charges 12.70
Dec 4, 2018 IDA-60670 Int Charges 12.70
Dec 4, 2018 IDA-60670 Int Charges 21.16
Dec 1, 2019 IDA-60670 Int Charges 4.52
Dec 1, 2019 IDA-60670 Int Charges 4.52
Dec 4, 2019 IDA-60670 Loan Disb 11,794.54
Dec 1, 2019 IDA-60670 Int Charges 12,172.06
Jan 15, 2020 IDA-60670 Loan Disb 11,794.53
Jan 21, 2020 IDA-60670 Loan Disb 6,906.25
Feb 27, 2020 IDA-60670 Loan Disb 29,503.48
Dec 12, 2019 IDA-60670 Loan Disb 12,350.00
Dec 1, 2019 IDA-60670 Int Charges 12,172.06
Dec 1, 2019 IDA-60670 Int Charges 19,241.61
Mar 23, 2020 IDA-60670 Loan Disb 17,000.31
Mar 19, 2020 IDA-60670 Loan Disb 11,794.52
Mar 9, 2020 IDA-60670 Loan Disb 7,393.76
Aug 22, 2019 IDA-60670 Loan Disb 8,603.16
Oct 24, 2019 IDA-60670 Loan Disb 259,946.02
Nov 27, 2019 IDA-60670 Loan Disb 6,494.28
Sep 20, 2019 IDA-60670 Loan Disb 17,346.88
Oct 15, 2019 IDA-60670 Loan Disb 13,697.38
Sep 20, 2019 IDA-60670 Loan Disb 8,848.34
Jun 1, 2019 IDA-60670 Int Charges 178.37
Jun 1, 2019 IDA-60670 Int Charges 2,888.99
Jun 1, 2019 IDA-60670 Int Charges 2,888.99
Nov 1, 2019 IDA-60670 Loan Disb 18,646.60
Nov 7, 2019 IDA-60670 Loan Disb 41,860.00
Jul 26, 2019 IDA-60670 Loan Disb 25,394.76
Nov 15, 2019 IDA-60670 Loan Disb 13,253.04
Oct 22, 2019 IDA-60670 Loan Disb 10,075.00
Oct 22, 2019 IDA-60670 Loan Disb 45,149.00
Sep 11, 2019 IDA-60670 Loan Disb 27,394.75
Jun 1, 2019 IDA-60670 Int Charges 4,815.00
Nov 20, 2019 IDA-60670 Loan Disb 24,414.86
Aug 28, 2019 IDA-60670 Loan Disb 26,934.39
Dec 4, 2018 IDA-60670 Int Charges 228.52
Dec 4, 2018 IDA-60670 Int Charges 228.52
Dec 4, 2018 IDA-60670 Int Charges 201.22
Mar 12, 2019 IDA-60670 Loan Disb 13,697.38
Mar 20, 2019 IDA-60670 Loan Disb 599,930.00
Mar 25, 2019 IDA-60670 Loan Disb 434,485.00
Jun 27, 2019 IDA-60670 Loan Disb 29,167.89
Apr 5, 2019 IDA-60670 Loan Disb 13,697.38

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name Review Date
Financial Management Moderately Satisfactory 2024-06-14
Overall Safeguards Rating Moderately Unsatisfactory 2024-06-14
Progress towards achievement of PDO Satisfactory 2024-06-14
Project Management Satisfactory 2024-06-14
Monitoring and Evaluation Satisfactory 2024-06-14
Overall Implementation Progress (IP) Satisfactory 2024-06-14
Procurement Moderately Satisfactory 2024-06-14

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATORBASELINECURRENTTARGET
  • Number of people receiving tuberculosis treatment in accordance with the national guidelines (NCD)Value6169.003358.007100.00
    DateAugust 31, 2016June 30, 2023March 31, 2024
    Comment
  • Number of people receiving tuberculosis treatment in accordance with national guidelines (Daru, Western Province)Value480.00133.00612.00
    DateAugust 31, 2016March 31, 2023March 31, 2024
    Comment
  • Proportion of new and relapse TB patients tested using a WHO-recommended rapid test (GeneXpert) at time of diagnosis (NCD)Value10.0066.0090.00
    DateAugust 31, 2016June 30, 2023March 31, 2024
    Comment
  • Proportion of new and relapse TB patients tested using a WHO-recommended rapid test (GeneXpert) at time of diagnosis (Daru, WesternProvince)Value10.0096.0090.00
    DateAugust 31, 2016March 31, 2023March 31, 2024
    Comment
  • TB treatment success rate for DS TB (NCD)Value56.0089.5085.00
    DateAugust 31, 2016June 30, 2023March 31, 2024
    Comment
  • TB treatment success rate for DR TB (NCD)Value44.0052.0075.00
    DateAugust 31, 2016December 31, 2022March 31, 2024
    Comment
  • TB treatment success rate for DR TB for females (NCD)Value0.0068.0075.00
    DateAugust 31, 2016December 31, 2022March 31, 2024
    Comment

INTERMEDIATE RESULTS INDICATORS

INDICATORBASELINECURRENTTARGET
  • Population-based screening in Daru is completeValueNoYesYes
    DateAugust 31, 2016December 31, 2021March 31, 2024
    Comment
  • Culture conversion rate among DR TB cases (NCD)Value0.0047.0075.00
    DateAugust 31, 2016December 31, 2021March 31, 2024
    Comment
  • Timely delivery of annual report compiled by NTPValueNoYesYes
    DateAugust 31, 2016June 30, 2023March 31, 2024
    Comment
  • Population-based screening in NCD is ongoingValueNoNoYes
    DateJanuary 1, 2022June 30, 2023March 31, 2024
    Comment
  • Number of BMUs using e-health information system for TB case and laboratory management in targeted geographic areas (NCD & Western Province)Value0.0014.0020.00
    DateAugust 31, 2016June 30, 2023March 31, 2024
    Comment
  • Number of BMUs with functioning TB Smear microscopy (NCD)Value7.007.0014.00
    DateAugust 31, 2016June 30, 2023March 31, 2024
    Comment
  • Carry out semi-annual review meeting which involves TB development partners and government agencies to review the progress and makethe consolidated integrated work plan and budgetValueNoNoYes
    DateAugust 31, 2016June 30, 2023March 31, 2024
    Comment
  • Number of BMUs with functioning TB Smear microscopy (Western Province)Value2.006.006.00
    DateAugust 31, 2016June 30, 2023March 31, 2024
    Comment
  • Citizens and/or communities involved in planning/ implementation/ evaluation of development programsValueNoYesYes
    DateAugust 31, 2016December 31, 2022March 31, 2024
    Comment
  • Number of BMUs with functioning GeneXpert (NCD)Value3.007.0014.00
    DateAugust 31, 2016March 31, 2023March 31, 2024
    Comment
  • A reduction in lost to follow up of DS TB patients (NCD)Value10.004.005.00
    DateAugust 31, 2016June 30, 2023March 31, 2024
    Comment
  • Project-supported organization(s) publishing reports containing information on feedback received from citizens and/or communities and if/how this feedback has been usedValueNoYesYes
    DateAugust 31, 2016June 30, 2023March 31, 2024
    Comment
  • Number of BMUs with functioning GeneXpert (Western Province)Value2.008.006.00
    DateAugust 31, 2016June 30, 2023March 31, 2024
    Comment
  • A reduction in lost to follow up of DR TB patients (NCD)Value12.0010.005.00
    DateAugust 31, 2016December 31, 2022March 31, 2024
    Comment
  • Number of BMUs where all clinical staff have been trained/retrained on TB and DR TB (NCD and Western Province)Value0.0020.0020.00
    DateAugust 31, 2016June 30, 2023March 31, 2024
    Comment